Health care policy seeks to ensure that citizens are protected from the financial risk associated with needing health care. Yet rising health care costs in many countries are leading to a greater reliance on out-of-pocket (OOP) measures. This paper uses 2010 household survey data from seven countries to measure and compare the burden OOP expenses place on individuals. It compares countries based on the extent to which citizens with health problems devote a large share of their income to OOP expenses. The paper finds that in all countries but France, and to a lesser extent Slovenia, citizens with health problems face considerably higher medical costs than do those without. As many as one-quarter of less healthy citizens in the US, Poland, Russia and Israel devote a large share of their income to OOP expenses. The paper also finds a strong crossnational correlation between the degree to which citizens face high OOP expenses, and the disparities in OOP expenses between those with and without health problems. The levels of high OOP spending uncovered, and their inequitable impact on those with health problems in the seven countries, underscore the potential for OOP measures to undermine core objectives of health care systems, including those of equitable financing, equal access, and improved health among the population.
Introduction
The central purpose of health insurance is to pool the risk of high medical expenses so that these costs are instead spread across the population. Yet over the last decade, countries have responded to rising health care costs by introducing greater cost-sharing measures so that the users of health care face larger expenses [1] [2] [3] [4] [5] . This trend raises the question of how well the design of health insurance in different countries accomplishes the goal of protecting citizens from the risk of large out-of-pocket (OOP) expenses.
Certainly, relying on the users of health care to pay some (or occasionally even all) of their medical expenses can be good policy: It can help to reduce the risk of moral hazard associated with insurance by reducing the less valuable uses of health care dollars [6, 7] . In many instances, paying out-of-pocket (OOP) can also be fairer than paying though insurance as some health expenses reflect individuals' preferences and income rather than medical necessity.
But high OOP requirements can also undermine the fundamental goals of a nation's health care system. They can render the financing of medical care less equitable, as paying for health care out-of-pocket is generally the most regressive way to finance it [8, 9] . When they are high, OOP requirements can also cause some to meet their health care needs only by sacrificing other essential purchases, such as for food, shelter and education. Meeting these expenses also requires some to assume debt or liquidate assets intended for other purposes [10, 11] . Not surprisingly, such ways of coping with high OOP requirements have been found to be more common among those in poor health and/or with chronic health problems [11, 12] .
Most importantly, paying for health care out-of-pocket can deter individuals from medical care, pharmaceutical products, and other needed medical goods [11, [13] [14] [15] [16] [17] [18] [19] . The poor [14, 19] , elderly [19] , and those with health problems [11, 20] have been shown to be the most sensitive to OOP requirements. Moreover, not only can cost-sharing practices lead to a reduction in the use of medical services and a weaker adherence to medication therapies, they have also been shown to result in poorer health outcomes [13, 19, 21] . For these reasons, researchers and policy makers are paying increased attention to the amount citizens pay out-of-pocket to receive medical services and products [1, [3] [4] [5] [22] [23] [24] [25] .
Yet very few studies investigate citizens' exposure to high OOP spending within a crossnational context. Making cross-country comparisons based on single country studies is generally difficult, as these comparisons are compromised by differences in the data sets, or in how out-ofpocket expenditures or income are defined and measured. However, cross-national comparisons are of increasing relevance, as countries face the similar public health challenges of reducing health care costs, distributing these costs fairly, and assuring equitable access to health care-all while meeting the growing medical needs of an aging population. How OOP expenditures feature into meeting or detracting from these goals is of growing concern in nearly all developed countries. Improved cross-national comparisons can aid in understanding the link between the scope and design of health insurance and the distribution of OOP expenditures. Such comparisons should also be included in comparative evaluations of how well countries meet their common health care objectives.
This paper contributes to a cross-national comparison of the burden created by out-ofpocket expenses by using nationally-representative household survey data from seven developed countries, where the data have been harmonized for the purpose of allowing cross-national comparisons. The paper matches groups of individuals across the seven countries based on their common responses to questions regarding their health, and compares these groups with respect to the percentage of household income spent on OOP expenditures. It then assesses the seven countries based on the frequency of high OOP expenses among those with similar health indicators, and the amount spent on OOP expenses at the tail end of the spending distribution (both defined below). The paper provides some of the best evidence to date on variation among countries in the degree to which those most in need of health care face large financial barriers to gaining access to it.
Methods
This paper measures the frequency with which citizens providing the same response to questions regarding their health (described below) in seven countries face high OOP expenses, where "high" is measured uniformly across the seven countries. An online Appendix A provides information and notes on each data set used. Table 1 provides summary data for each country on household income and OOP expenses; as shown there, the number of observations in each country ranges from 3,900 in Slovenia to over 200,000 in the United States. All calculations presented here are based on weighted individual-level observations.
Table 1 here
As an indication of the representativeness of the countries chosen for this study, Table 2 compares a large number of developed countries based on two measures of their OOP spending per capita) spend significantly below the average, Israel and Russia (around $500) are fairly typical, and the US ($988) is at the high end of the spending spectrum. Table 2 here Table 3 provides further detail on differences among the seven countries in this study.
The first three columns present the relative importance in each nation of the three primary funding sources for the country's health care system: general tax revenue, social insurance payments, and private payments (the combination of private insurance and OOP expenses). As shown, France, Japan, Poland and Slovenia rely primarily on social insurance payments, whereas
Russia and the US rely to a greater degree on private funding sources. Israel relies on a mixture of all three sources. Prior research has found that general taxes tends to result in the least regressive way to finance health care, while private financing tends to be the most [8] . Where available, the last column of Table 3 identifies the policies used in countries to limit OOP expenses. As shown, the mix of policies is typical of what is found in other countries: special protection is offered to certain populations (typically the ill, children elderly, and/or the poor), and in some instances, countries have established income-based limits on OOP expenditures. Table 3 here
Out-of-pocket Spending. Out-of-pocket spending is defined by LIS as total household expenditures on medical products, appliances and equipment, outpatient services and hospital services, and excludes health insurance premiums. The countries in this study adhere relatively closely to this definition, which comes from Code 06 of the United Nation's Classification of Individual Consumption According to Purpose. To verify the quality of LIS's OOP spending data, we compare OOP spending in each of the seven surveys with amounts published by the OECD (compare Table 1 with Table 2 ). All seven country estimates from LIS fall within 72% to 96% of the OECD's estimates. That per-capita OOP estimates from LIS are below the OECD's is expected: household surveys generally exclude the institutionalized population (e.g., those in long-term care facilities) and individuals who died earlier in the year. For both of these populations, OOP spending can be high. Recent evidence also raises questions about the reliability of the OECD's estimates [26] .
High Medical Expenses. This paper follows the common practice of labeling households as having high OOP spending when the amount they spend exceeds a certain percentage of income [1, 5, 9, 22, 27] . Especially in developed countries, income is the most commonly used measure of a household's ability to pay. In this paper all members of a household are designated as having high OOP spending when the amount spent exceeds 10% of their income, or 5% if the household is in poverty, both of which are defined below. This measurement reflects the most common practice of using a 10% threshold, but often lowering it if the household is poor [1, 28, 29] . It should be noted, however, that this measure of "high spending" is conservative insofar as it entails an arbitrary division between the "poor" and the "non-poor." It also does not capture as high-spenders those with low costs due to their underutilization of medical care or medication, which could be significant [30] .
Income. LIS data provide excellent information on household income which is consistently measured across different countries. The paper defines income as disposable income, which is superior to other measures since it takes into account the value of government taxes paid and social transfers received. This is especially important for those with health problems, since disposable income includes any benefits received from disability, social insurance, social assistance, and public pension policies. As with OOP spending, income is measured at the household level. To answer the first question, Table 4 
Table 4 here
To compare the incidence of high OOP spending by citizens' health status in the seven countries, Table 4 presents estimates of the percentage of individuals with large OOP expenses by health status based on each of the three different indicators of health problems previously discussed ("Disability", "Illness", and "Poor Health"). percentile spent 9% of their income on OOP expenses, whereas the same group at the same point of the spending distribution in Israel spent 18% of their income on OOP expenses. Together these two statistics provide comparative indicators of the extent to which health care costs within a county fall disproportionately on those who need it more: the first measures the prevalence of high OOP costs, and the second measures how high these costs can reach.
As Table 3 shows, differences in the incidence of high OOP spending between the disabled and non-disabled population exceeds ten percentage points in the United States, Poland, Israel and Russia, while differences in Slovenia (four percentage points) are the smallest.
Comparing rates between those with and without a chronic illness in France and Japan reveals small difference in the prevalence of high OOP expenses between these two groups, perhaps reflecting the weaker nature of this indicator of individuals' health status.
The last two columns in Table 4 With the exception of the Illness variable-which is very likely a weak indicator of health status (see online Appendix A)--the results reveal that those with health problems are exposed to a significantly higher risk of large OOP spending than are those without them: in all countries, the risk roughly doubles for this population compared with those without health problems. But in France especially, and to a lesser extent Slovenia, "greater risk" is relative to a population provided significant protection from high financial costs. In absolute terms, the overall estimates show that a quarter or more of citizens with health problems in Poland, Russia, the US and Israel had high OOP expenses in 2010, with slightly better outcomes in Japan.
Comparing spending levels at the 90 th percentile for each group in the seven countries similarly reveals large difference between them: typically those with health problems spend about 75 percent more than do those without health problems. For instance, a disabled person at the 90 percentile of spending among the disabled in Poland devoted 16% of her income to OOP expenses, whereas a non-disabled at this point of the non-disabled spending distribution in
Poland spent only 9% of income on OOP expenses. health policy within a country exposes a larger percentage of citizens to substantial costs from using medical services, then we would expect that additional exposure to fall disproportionately on those who most need health care and medical products.
Figure 1 here
The sample of counties in this study, then, reveals a strong pattern where exposure to a higher risk of incurring large OOP expenses places a more uneven financial burden on those with health problems versus those without. But not only do we see this association, but we also see that a higher exposure to large OOP expenses is associated with more extreme levels of OOP requirements at the household level. This is shown in Figure 2 , where the X axis once again measures the incidence of high OOP spending in each country, but the Y axis now captures the amount spent on OOP expenses as a share of income at the 90 th percentile of spending among those with indicators of health problems (see Table 4 ). As Figure 2 shows, nations that expose citizens to a higher risk of large OOP expenses (X axis), also expose their citizens with health problems to especially high levels of spending requirements. For instance in Russia (the northeast corner of Figure 2 ), 17% of its population had high OOP expenses in 2010, and among those reporting to be disabled, the 90 th percentile of OOP/income spending reached 20%. The distinct pattern depicted in Figure 2 suggests a separate manifestation of the problem associated with high exposure to OOP expenses: it tends to also expose citizens in poor health to extremely large levels of out-of-pocket medical expenses.
Figure 2 here
In our sample of countries, then, the degree of exposure to large OOP expenses is closely associated with the extent to which those with health problems disproportionately face high OOP expenses, and the chance that these costs will reach extremely high levels. This association becomes even more concerning when one examines who it is that tends to have health problems. Table 5 displays the age and income profile of those reporting health problems in the seven countries. On average, those with indicators of health problems were about twice as likely to be poor, and several times more likely to be 65 years or older. As shown elsewhere, the risk of having large OOP expenses is especially pronounced among the poor and elderly, where it is not uncommon for one-quarter or more of poor citizens to devote at least 5% of their income to outof-pocket expenses [31] . Thus, in the sample countries here, exposure to high OOP expenses disproportionately shifts health care financing to those with health problems, thereby placing a greater financial burden on the poor and elderly--the precise citizens least able to bear these expenses, and the ones most likely to respond to them by reducing their health care consumption [11, 14, 19, 20] . Table 5 here
Discussion
This study presents comparable cross-national indicators of the incidence of high out-ofpocket medical expenses among those with similar indicators of their health status. Within each of the seven countries, the design and scope of insurance leaves the unhealthy more exposed to high OOP costs than it does the healthy. Looking across countries, the absolute magnitude of this risk varies considerably. Health policy in France provides the best financial protection against the costs associated with adverse health outcomes, with Slovenia a distant second.
Numerous measures in France help account for citizens' minimal exposure to high OOP expenses. For one, most French citizens purchase secondary private insurance to cover the at times extensive cost-sharing requirements of public insurance. And those below a particular income threshold are provided supplemental public insurance at no cost. Many vulnerable citizens (including those with particular health problems) are also exempt from all OOP requirements [32] . These measures explain why overall, OOP expenditures account for only 7.5% of France's health care expenditures. Indeed, the results here show a .78 correlation between a country's reliance on OOP expenditures (column 1 of Table 2 ) and the percent of citizens with high OOP expenses (Column 1 Table 4 ), and a stronger .83 correlation between a reliance on OOP and the amount spent by those at the 90 th spending percentile (Column 1 Table   4 ).
By contrast, the US, Poland, Russia and Israel stand out for the significant exposure their citizens have to high OOP expenses, an outcome that the paper shows in these countries disproportionately shifts the financing of health care costs to low-income households, citizens in poor health, and the elderly. Moreover, it also is associated with these individuals being more exposed to the risk of extremely high OOP expenses. Overall in our sample, nations relying on private spending sources do tend to place a more inequitable financial burden on those with health problems; however, this association is also almost completely attributable to the OOP component of private expenditures rather than a reliance on private insurance.
There are a couple of important limitations to this study. First, it estimates the risk of high OOP spending by actual spending patterns. As such it does not count those for whom OOP spending falls below the threshold of "high" only because they forgo needed medical services and products rather than pay its cost. This omission may lead to significantly underestimating the risk of incurring high medically-related costs [30] , especially in countries with high levels of OOP requirements [33] . Second, the comparisons are based on self-reported measures of health, and the definitions of "Illness" and "Disability" used in each of the countries often differed. For this reason, the comparisons across countries for these variables should be considered suggestive rather than exact, and likely underestimate true disparities within countries. Third, no single measure of citizens' health status is available for all seven countries.
Finally, in measuring the frequency and magnitude of large OOP spending, the paper
does not address what the right amount or the appropriate conditions are for individuals to pay out-of-pocket, as opposed to pre-paying collectively via taxes or premiums. Paying out-ofpocket may advance the objective of constraining the burden medical care places on public budgets and private premiums, and moderating citizens' incentive to overconsume health care [6, 7] . It may also reflect a preferred reduction in the cost of premiums in exchange for higher OOP expenses. Yet the levels of high OOP spending uncovered in most of the countries here, and their disparate effect on individuals with health problems, the poor and the elderly, underscores its widespread potential to undermine core objectives of health care systems, including those of equitable financing, equal access, and improved health among the population.
Conclusions
Despite universal insurance in six of the seven countries in this study, and the widespread existence of policies that supposedly limit citizens' financial exposure to high OOP expenses [4, 34, 35, see Table 3 ], the paper finds that large levels of OOP spending are common in all but
France. It is perhaps noteworthy that according to one attempt to classify nations' health care systems, France, Poland, Japan and Israel all have common institutional arrangements for regulating, financing, and providing health care within their nation [36] . Yet according to this paper's findings, these similarities do not translate into similar levels of financial protection.
Exactly how countries do and do not accomplish the level of financial protection each provides deserves further detailed analyses, although as previously discussed, health policy in France is specifically designed to restrict the potential for OOP expenses at the household level to climb.
Indeed, the findings here indicate the centrality of this feature of health care policy to achieve equitable financing of and equal access to health care.
In addition to more closely investigating how and why OOP expenses in countries can mount (or not), another implication of this study is the increasing importance of monitoring the incidence of high OOP spending within countries. That it is a common occurrence in many countries reveals an aspect of nations' health care system that is currently not very visible.
Collecting and publicizing this data is especially important given that health care costs are rising,
as have out-of-pocket costs in most countries.
A challenge for public health is making sure that OOP requirements are consistent with the goals of financing equity, equal access, and improved medical outcomes. For countries to attain financial protection on par with that achieved in France, they will need to enact more comprehensive income-based limits on OOP spending than currently exist in most countries.
However, the magnitude of financial risk revealed here indicates that in order to reduce health care costs, countries should seek alternative methods to the one examined here: shifting the cost to those who need health care. 
